Engineered T cells for pancreatic cancer treatment

OBJECTIVE: Conventional chemotherapy and radiotherapy produce marginal survival benefits in pancreatic cancer, underscoring the need for novel therapies. The aim of this study is to develop an adoptive T cell transfer approach to target tumours expressing prostate stem cell antigen (PSCA), a tumour-...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Katari, Usha L, Keirnan, Jacqueline M, Worth, Anna C, Hodges, Sally E, Leen, Ann M, Fisher, William E, Vera, Juan F
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Blackwell Publishing Ltd 2011
Pynciau:
Original Articles
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC3183449/
https://ncbi.nlm.nih.gov/pubmed/21843265
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1477-2574.2011.00344.x
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg